Filing Flows › Halozyme Therapeutics (HALO) › Q1 2025
Halozyme Therapeutics (HALO) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 6, 2025
Halozyme Therapeutics (HALO) reported revenue of $265M for the first quarter 2025 (Q1 2025), +35% from a year earlier and -11% from the quarter before. Operating margin was 53.4%, net earnings $118M (44.6% of revenue).
Halozyme Therapeutics, Q1 2025: revenue $265M (+35% year over year), operating margin 53.4%, net earnings $118M, operating cash flow $154M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $265M | -11% | +35% |
| Operating profit | $142M | -19% | +48% |
| Net earnings | $118M | -14% | +54% |
| Operating cash flow | $154M | -14% | +19% |
| Free cash flow | $153M | -13% | +22% |
What changed
Revenue was $264.9M in Q1 2025, up 35% year over year and down 11% from the previous quarter. Royalties was the largest line at 64% of revenue. Royalties added $47.6M year over year (up 39%), 69% of the total change.
Operating profit was $141.5M, a 53.4% margin (up 4.7 points year over year). Of the extra revenue versus a year earlier, 67% reached operating profit, above the 49% margin then. Total costs grew 23% against revenue growth of 35%. The fastest-growing cost line was Cost of revenue (+71%). Net earnings were $118.1M, up 54% year over year. The effective tax rate was 17.9%.
Operating cash flow was $154.2M (up 19% year over year), 131% of net earnings. Non-cash charges added back $2.7M of depreciation and amortization and $10.7M of share-based compensation. Working capital and other items added $22.8M. Capital expenditures of $0.9M left free cash flow of $153.3M.
Questions
What was Halozyme Therapeutics' revenue in the first quarter 2025?
Halozyme Therapeutics (HALO) reported revenue of $265M for the first quarter 2025 (Q1 2025), +35% from a year earlier and -11% from the quarter before.
Was Halozyme Therapeutics profitable in the first quarter 2025?
Operating profit was $142M (53.4% of revenue) and net earnings $118M.